找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Antibody Therapy; Substitution – Immun Paul Imbach Book 2018 Springer International Publishing AG, part of Springer Nature 2018 Immunoglobu

[复制链接]
楼主: Animosity
发表于 2025-3-28 14:53:37 | 显示全部楼层
Einführung in die theoretische Gasdynamikin practical clinical science. Substitutive administration of a new concentrate of a human immunoglobulin (IgG) preparation resulted in regular minimal platelet increases in a child with a primary immunodeficiency and low platelet counts despite normal platelet production. The investigators conclude
发表于 2025-3-28 22:41:14 | 显示全部楼层
Einführung in die theoretische Gasdynamikestones in the history of human immunoglobulins since the initial observation by Ogden C. Bruton who described replacement therapy in a single boy with agammaglobulinemia. Since then, the preparations used for treatment have been markedly improved with respect to tolerability, clinical efficacy, and
发表于 2025-3-28 23:11:57 | 显示全部楼层
发表于 2025-3-29 04:24:39 | 显示全部楼层
Kapitel 7: Erfassung sozialer Phänomeneoimmune syndromes. Although the precise mechanism of action of IVIg as an immunomodulatory agent has been elusive, many theories over the years have been postulated. These theories include mononuclear phagocytic system blockade, autoantibody neutralization, increased clearance of pathogenic autoanti
发表于 2025-3-29 08:53:31 | 显示全部楼层
发表于 2025-3-29 15:11:12 | 显示全部楼层
Kapitel 10: Theorien der Gegenwartously untreatable, or poorly managed, conditions. Based on controlled trials, IVIg is approved as first-line therapy for patients with GBS, CIDP, and multifocal motor neuropathy. In CIDP, where the largest controlled study was performed, IVIg is also effective in the chronic management of the diseas
发表于 2025-3-29 18:47:07 | 显示全部楼层
Kapitel 6: Grundbegriffe und Datenerhebungwhen Furusho et al. (1984) and Newburger et al. (1986), respectively, reported the successful application of IVIg in Kawasaki syndrome. Seven years later, Dalakas et al. (1993) reported the first successful randomized controlled trial of IVIg in the treatment of dermatomyositis. Ever since, IVIg has
发表于 2025-3-29 23:13:03 | 显示全部楼层
发表于 2025-3-30 02:25:00 | 显示全部楼层
发表于 2025-3-30 04:39:30 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-18 12:02
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表